Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.

Published 20 Oct 2026, 19:39 UTC. Updated 20 Oct 2026, 21:49 UTC.

For years, artificial-intelligence evangelists have boasted about the technology’s capacity to revolutionize drug development and medical research.

Directly affected

No company is named in this report.

Indirectly affected

SPY SPDR S&P 500
The broad U.S. stock market
TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
QQQ Invesco QQQ
Large technology stocks
GLD SPDR Gold Shares
Gold can move with the broad market

Price reaction, T-5 to T+3

Ticker	T-5	T-3	T-1	T0	T+1	T+2	T+3
SPY	—	—	—	—	—	—	—
TLT	—	—	—	—	—	—	—
QQQ	—	—	—	—	—	—	—
GLD	—	—	—	—	—	—	—

For years, artificial-intelligence evangelists have boasted about the technology’s capacity to revolutionize drug development and medical research.

Source: MarketWatch

This story

12 out of 100

“Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.” scores 12 out of 100. The score uses 1 sources.

Ticker	T-5	T-3	T-1	T0	T+1	T+2	T+3
SPY	—	—	—	—	—	—	—
TLT	—	—	—	—	—	—	—
QQQ	—	—	—	—	—	—	—
GLD	—	—	—	—	—	—	—

Ticker	T-5	T-3	T-1	T0	T+1	T+2	T+3
SPY	—	—	—	—	—	—	—
TLT	—	—	—	—	—	—	—
QQQ	—	—	—	—	—	—	—
GLD	—	—	—	—	—	—	—

Ticker	T-5	T-3	T-1	T0	T+1	T+2	T+3
SPY	—	—	—	—	—	—	—
TLT	—	—	—	—	—	—	—
QQQ	—	—	—	—	—	—	—
GLD	—	—	—	—	—	—	—